Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Rhea-AI Summary
Shoulder Innovations (NYSE: SI) will release fourth quarter and full year 2025 financial results after market close on March 10, 2026. Management will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026 to discuss results.
Dial-in numbers are (877) 407-8216 (U.S.) or (412) 902-1015 (international) with access code 13758375. A live and archived webcast will be available in the Investor Relations section at https://ir.shoulderinnovations.com/.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
No peers with momentum signals or same-day headlines were provided, so the -7.13% move ahead of the earnings date screens as stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 03 | Conference participation | Neutral | -6.0% | Announced participation in BTIG MedTech and related investor meetings. |
| Dec 03 | Strategic partnership | Positive | +0.1% | Announced partnership to develop micro-robotic shoulder arthroplasty platform. |
| Nov 19 | Conference participation | Neutral | -4.8% | Management scheduled for Piper Sandler healthcare conference fireside chat. |
| Nov 18 | Product launch | Positive | +2.6% | Full commercial launch of InSet™ 70 humeral stem in shoulder arthroplasty line. |
| Nov 11 | Earnings update | Positive | +3.2% | Reported Q3 2025 results and raised full‑year 2025 revenue guidance. |
Recent news has been mostly positive (product, earnings, partnerships), with three instances where favorable updates aligned with positive price reactions and two neutral events coinciding with declines.
Over the past six months, Shoulder Innovations has issued a mix of commercial and financial updates, including a Q3 2025 report on Nov 11, 2025 featuring strong revenue growth and raised full-year guidance, plus the full commercial launch of the InSet™ 70 humeral stem in Sept 2025. Participation in investor conferences and a strategic robotic partnership rounded out the flow. Today’s earnings-date announcement follows this pattern of ongoing execution and investor outreach.
Market Pulse Summary
This announcement schedules the release of Shoulder Innovations’ Q4 and full-year 2025 results for March 10, 2026, with a conference call at 4:30 p.m. ET. In November 2025, the company reported strong Q3 growth and raised full-year revenue guidance, so investors may focus on whether upcoming figures confirm that trajectory. Recent insider activity has featured net buying, and prior news events have sometimes produced both aligned and divergent price reactions, underscoring execution and guidance as key watchpoints.
AI-generated analysis. Not financial advice.
Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13758375. A live and archived webcast of the event will be available in the "Investor Relations" section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-10-2026-302686865.html
SOURCE Shoulder Innovations
FAQ
When will Shoulder Innovations (SI) report Q4 and full year 2025 results?
What time is the Shoulder Innovations (SI) earnings call on March 10, 2026?
How can investors join the Shoulder Innovations (SI) March 10, 2026 conference call?
Where will the Shoulder Innovations (SI) webcast be available after the March 10, 2026 call?
Will Shoulder Innovations (SI) discuss guidance on the March 10, 2026 call?
What access code is required to join the Shoulder Innovations (SI) March 10, 2026 call?
